Top compounds associated with response to OR2T4


Feature Type Standardized
Nominal ANOVA
mRNA AUY922 GDSC1000 pan-cancer AAC 0.07 0.04
mRNA BAY 61-3606 GDSC1000 pan-cancer AAC 0.069 0.04
mRNA tubastatin A GDSC1000 pan-cancer AAC 0.062 0.04
mRNA navitoclax:piperlongumine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.071 0.04
mRNA KU 0060648 CTRPv2 pan-cancer AAC -0.07 0.04
mRNA Obatoclax Mesylate GDSC1000 pan-cancer AAC 0.068 0.04
mRNA JQ-1 GDSC1000 pan-cancer AAC 0.065 0.04
mRNA selumetinib:BRD-A02303741 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.068 0.04
mRNA AZD6244 CTRPv2 pan-cancer AAC -0.069 0.05
mRNA Vandetanib CTRPv2 pan-cancer AAC -0.07 0.05
Download CSV